Trilogy Capital’s Invesco BulletShares 2028 Corporate Bond ETF BSCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.94M Buy
242,601
+9,928
+4% +$203K 0.19% 89
2026
Q1
$4.75M Buy
232,673
+12,480
+6% +$257K 0.21% 77
2025
Q4
$4.54M Buy
220,193
+8,825
+4% +$182K 0.2% 78
2025
Q3
$4.35M Sell
211,368
-2,442
-1% -$50.1K 0.2% 73
2025
Q2
$4.38M Sell
213,810
-9,450
-4% -$192K 0.21% 63
2025
Q1
$4.54M Buy
223,260
+7,906
+4% +$160K 0.24% 62
2024
Q4
$4.34M Buy
+215,354
New +$4.37M 0.22% 76

Other funds holding BSCS

Trilogy Capital's BSCS Position: Q2 2026 in Review

Trilogy Capital increased its Invesco BulletShares 2028 Corporate Bond ETF (BSCS) stake by 4.3% in Q2 2026, buying an estimated $203K and bringing the position to 242,601 shares worth $4.94M. The position accounts for 0.19% of the portfolio, ranked #89.

Trilogy Capital first reported a position in BSCS in Q4 2024 and has held it in 7 quarters since. 399 funds tracked by Wall St. Rank hold BSCS as of Q2 2026.

  • Trilogy Capital held 242,601 shares of Invesco BulletShares 2028 Corporate Bond ETF worth $4.94M as of Q2 2026.
  • Trilogy Capital bought 9,928 Invesco BulletShares 2028 Corporate Bond ETF shares in Q2 2026, an estimated $203K.
  • Invesco BulletShares 2028 Corporate Bond ETF made up 0.19% of Trilogy Capital's portfolio in Q2 2026, its #89 holding.
  • Trilogy Capital first reported a position in Invesco BulletShares 2028 Corporate Bond ETF in Q4 2024 and has held it in 7 quarters since.
  • 399 funds tracked by Wall St. Rank held Invesco BulletShares 2028 Corporate Bond ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.